{name}
{subtitle}
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment
city
~15 mi. (Tula, Russia, +142 more cities)
facility
Tula Regional Clinical Hospital
biomarker
del(11)(q10), +27 more biomarkers
drug
imetelstat, +1 more drug
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
city
~94 mi. (Kaluga, Russia, +201 more cities)
facility
Kaluga Regional Clinical Hospital /ID# 221211
drug
azacitidine, +1 more drug